An interventional study of ESP Block and TAP Block in Post Operative Pain, sponsored by Mongi Slim Hospital. Status unknown at 1 site in Tunisia. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2019-11-29.
Sponsored by Mongi Slim Hospital · Not applicable, Interventional, and Treatment
This study aim to compare the efficiency and the analgesic effect of Erector Spinal Plane Block versus TAP Block after laparoscopic cholecystectomy.
This study will include patients scheduled for laparoscopic cholecystectomy, ASA status 1 or 2. patients will be randomized in 2 groups to recieve post operative analgesia with -ESP block: bilateral injection of 20 ml of isobaric Bupivacain 0,375% in the paraverebral space T5.
or
-TAP block: bilateral injection of 15 ml of Isobaric Bupivacain 0,5%
5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.
This study's planned enrollment of 80 is close to the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.
Browse Pain, Postoperative studies →Mongi Slim Hospital is the lead sponsor of 37 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
ESP block: bilateral injection of 20 ml of isobaric Bupivacain 0,375% in the paraverebral space T5.
Procedure: ESP Block
TAP block: bilateral injection of 15 ml of Isobaric Bupivacain 0,5%
Procedure: TAP Block
ESP block: bilateral injection of 20 ml of isobaric Bupivacain 0,375% in the paraverebral space T5.
TAP block: bilateral injection of 15 ml of Isobaric Bupivacain 0,5%
Post Operative analgesia
Post operative analgesia assessed with Numerical rating scale (0=minimum, 10= Maximum)
Time frame: 24 hours after intervention
post operative analgesic consumption
Amount of Morphin needed for analgesia
Time frame: 24 hours after intervention
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mongi Slim Hospital